Načítá se...

Novel mechanism of drug resistance to proteasome inhibitors in multiple myeloma

Multiple myeloma (MM) is a cancer caused by uncontrolled proliferation of antibody-secreting plasma cells in bone marrow, which represents the second most common hematological malignancy. MM is a highly heterogeneous disease and can be classified into a spectrum of subgroups based on their molecular...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Clin Oncol
Hlavní autoři: Zhou, Jianbiao, Chng, Wee-Joo
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6766463/
https://ncbi.nlm.nih.gov/pubmed/31572666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v10.i9.303
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!